Machine learning-based typing of Salmonella enterica O-serogroups by the Fourier-Transform Infrared (FTIR) Spectroscopy-based IR Biotyper system.


Journal

Journal of microbiological methods
ISSN: 1872-8359
Titre abrégé: J Microbiol Methods
Pays: Netherlands
ID NLM: 8306883

Informations de publication

Date de publication:
10 2022
Historique:
received: 14 06 2022
revised: 30 08 2022
accepted: 30 08 2022
pubmed: 10 9 2022
medline: 6 10 2022
entrez: 9 9 2022
Statut: ppublish

Résumé

Salmonella enterica is among the major burdens for public health at global level. Typing of salmonellae below the species level is fundamental for different purposes, but traditional methods are expensive, technically demanding, and time-consuming, and therefore limited to reference centers. Fourier transform infrared (FTIR) spectroscopy is an alternative method for bacterial typing, successfully applied for classification at different infra-species levels. This study aimed to address the challenge of subtyping Salmonella enterica at O-serogroup level by using FTIR spectroscopy. We applied machine learning to develop a novel approach for S. enterica typing, using the FTIR-based IR Biotyper® system (IRBT; Bruker Daltonics GmbH & Co. KG, Germany). We investigated a multicentric collection of isolates, and we compared the novel approach with classical serotyping-based and molecular methods. A total of 958 well characterized Salmonella isolates (25 serogroups, 138 serovars), collected in 11 different centers (in Europe and Japan), from clinical, environmental and food samples were included in this study and analyzed by IRBT. Infrared absorption spectra were acquired from water-ethanol bacterial suspensions, from culture isolates grown on seven different agar media. In the first part of the study, the discriminatory potential of the IRBT system was evaluated by comparison with reference typing method/s. In the second part of the study, the artificial intelligence capabilities of the IRBT software were applied to develop a classifier for Salmonella isolates at serogroup level. Different machine learning algorithms were investigated (artificial neural networks and support vector machine). A subset of 88 pre-characterized isolates (corresponding to 25 serogroups and 53 serovars) were included in the training set. The remaining 870 samples were used as validation set. The classifiers were evaluated in terms of accuracy, error rate and failed classification rate. The classifier that provided the highest accuracy in the cross-validation was selected to be tested with four external testing sets. Considering all the testing sites, accuracy ranged from 97.0% to 99.2% for non-selective media, and from 94.7% to 96.4% for selective media. The IRBT system proved to be a very promising, user-friendly, and cost-effective tool for Salmonella typing at serogroup level. The application of machine learning algorithms proved to enable a novel approach for typing, which relies on automated analysis and result interpretation, and it is therefore free of potential human biases. The system demonstrated a high robustness and adaptability to routine workflows, without the need of highly trained personnel, and proving to be suitable to be applied with isolates grown on different agar media, both selective and unselective. Further tests with currently circulating clinical, food and environmental isolates would be necessary before implementing it as a potentially stand-alone standard method for routine use.

Sections du résumé

BACKGROUND
Salmonella enterica is among the major burdens for public health at global level. Typing of salmonellae below the species level is fundamental for different purposes, but traditional methods are expensive, technically demanding, and time-consuming, and therefore limited to reference centers. Fourier transform infrared (FTIR) spectroscopy is an alternative method for bacterial typing, successfully applied for classification at different infra-species levels.
AIM
This study aimed to address the challenge of subtyping Salmonella enterica at O-serogroup level by using FTIR spectroscopy. We applied machine learning to develop a novel approach for S. enterica typing, using the FTIR-based IR Biotyper® system (IRBT; Bruker Daltonics GmbH & Co. KG, Germany). We investigated a multicentric collection of isolates, and we compared the novel approach with classical serotyping-based and molecular methods.
METHODS
A total of 958 well characterized Salmonella isolates (25 serogroups, 138 serovars), collected in 11 different centers (in Europe and Japan), from clinical, environmental and food samples were included in this study and analyzed by IRBT. Infrared absorption spectra were acquired from water-ethanol bacterial suspensions, from culture isolates grown on seven different agar media. In the first part of the study, the discriminatory potential of the IRBT system was evaluated by comparison with reference typing method/s. In the second part of the study, the artificial intelligence capabilities of the IRBT software were applied to develop a classifier for Salmonella isolates at serogroup level. Different machine learning algorithms were investigated (artificial neural networks and support vector machine). A subset of 88 pre-characterized isolates (corresponding to 25 serogroups and 53 serovars) were included in the training set. The remaining 870 samples were used as validation set. The classifiers were evaluated in terms of accuracy, error rate and failed classification rate.
RESULTS
The classifier that provided the highest accuracy in the cross-validation was selected to be tested with four external testing sets. Considering all the testing sites, accuracy ranged from 97.0% to 99.2% for non-selective media, and from 94.7% to 96.4% for selective media.
CONCLUSIONS
The IRBT system proved to be a very promising, user-friendly, and cost-effective tool for Salmonella typing at serogroup level. The application of machine learning algorithms proved to enable a novel approach for typing, which relies on automated analysis and result interpretation, and it is therefore free of potential human biases. The system demonstrated a high robustness and adaptability to routine workflows, without the need of highly trained personnel, and proving to be suitable to be applied with isolates grown on different agar media, both selective and unselective. Further tests with currently circulating clinical, food and environmental isolates would be necessary before implementing it as a potentially stand-alone standard method for routine use.

Identifiants

pubmed: 36084763
pii: S0167-7012(22)00159-2
doi: 10.1016/j.mimet.2022.106564
pii:
doi:

Substances chimiques

Culture Media 0
Water 059QF0KO0R
Ethanol 3K9958V90M
Agar 9002-18-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106564

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest O.J.L, F.G., S.L., M.A., M.P., S.Z., M.B., J.S., H.F., D.D., Y.F., Z.N., J.S., L.O., A.C.V., U.S.J., H.M.H., A.L., S.A., S.P., L.S., A.W., S.R., R.M.H., J.M. and A.B.P. declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. M.C., N.M. and M.K. are Bruker's employees.

Auteurs

Miriam Cordovana (M)

Bruker Daltonics GmbH & Co. KG, 28359 Bremen, Germany. Electronic address: miriam.cordovana@bruker.com.

Norman Mauder (N)

Bruker Daltonics GmbH & Co. KG, 28359 Bremen, Germany. Electronic address: norman.mauder@bruker.com.

Olivier Join-Lambert (O)

Université de Caen, Normandie, 14032, Cedex 5, Caen, France. Electronic address: olivier.join-lambert@unicaen.fr.

François Gravey (F)

Université de Caen, Normandie, 14032, Cedex 5, Caen, France.

Simon LeHello (S)

Université de Caen, Normandie, 14032, Cedex 5, Caen, France. Electronic address: Lehello-s@chu-caen.fr.

Michel Auzou (M)

Université de Caen, Normandie, 14032, Cedex 5, Caen, France. Electronic address: auzou-m@chu-caen.fr.

Monica Pitti (M)

Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d'Aosta, (SS Patologia Animale - Simona; SS Microbiologia Comparativa Specialistica - Centro di Riferimento Tipizzazione delle Salmonelle (CeRTiS) - Monica), via Bologna 148,Torino, Italy. Electronic address: monica.pitti@izsto.it.

Simona Zoppi (S)

Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d'Aosta, (SS Patologia Animale - Simona; SS Microbiologia Comparativa Specialistica - Centro di Riferimento Tipizzazione delle Salmonelle (CeRTiS) - Monica), via Bologna 148,Torino, Italy. Electronic address: simona.zoppi@izsto.it.

Michael Buhl (M)

Institute of Clinical Hygiene, Medical Microbiology and Infectiology, Paracelsus Medical University, Nuremberg, Germany. Electronic address: Michael.Buhl@klinikum-nuernberg.de.

Joerg Steinmann (J)

Institute of Clinical Hygiene, Medical Microbiology and Infectiology, Paracelsus Medical University, Nuremberg, Germany. Electronic address: Joerg.Steinmann@klinikum-nuernberg.de.

Hagen Frickmann (H)

Department of Microbiology and Hospital Hygiene, Bundeswehr Hospital Hamburg, 20359 Hamburg, Germany; Institute for Medical Microbiology, Virology and Hygiene, University Medicine Rostock, 18057 Rostock, Germany. Electronic address: frickmann@bnitm.de.

Denise Dekker (D)

Bernhard Nocht Institute for Tropical Medicine Hamburg, 20359 Hamburg, Germany. Electronic address: dekker@bnitm.de.

Yumiko Funashima (Y)

Department of Medical Technology and Sciences, School of Health Sciences, Fukuoka International University of Health and Welfare, 137-1 Enokizu, Okawa, Fukuoka, Japan. Electronic address: funashima@iuhw.ac.jp.

Zenzo Nagasawa (Z)

Department of Medical Technology and Sciences, School of Health Sciences, Fukuoka International University of Health and Welfare, 137-1 Enokizu, Okawa, Fukuoka, Japan. Electronic address: nagasa@iuhw.ac.jp.

József Soki (J)

Institute of Medical Microbiology, Albert Szent-Györgyi Health Centre and Medical School, University of Szeged, Szeged, Hungary. Electronic address: soki.jozsef@med.u-szeged.hu.

László Orosz (L)

Institute of Medical Microbiology, Albert Szent-Györgyi Health Centre and Medical School, University of Szeged, Szeged, Hungary. Electronic address: orosz.laszlo@med.u-szeged.hu.

Alida C Veloo (AC)

Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, 9700 AB Groningen, the Netherlands. Electronic address: a.c.m.veloo@umcg.nl.

Ulrik S Justesen (US)

Department of Clinical Microbiology, Odense University Hospital, 5000 Odense C, Denmark. Electronic address: Ulrik.Stenz.Justesen@rsyd.dk.

Hanne M Holt (HM)

Department of Clinical Microbiology, Odense University Hospital, 5000 Odense C, Denmark. Electronic address: Hanne.Holt@rsyd.dk.

Andrea Liberatore (A)

Operative Unit of Microbiology, IRCCS-Azienda Ospedaliero Policlinico Sant'Orsola-Universitaria di Bologna, 40138 Bologna, Italy. Electronic address: andrea.liberatore@studio.unibo.it.

Simone Ambretti (S)

Operative Unit of Microbiology, IRCCS-Azienda Ospedaliero Policlinico Sant'Orsola-Universitaria di Bologna, 40138 Bologna, Italy. Electronic address: simone.ambretti@aosp.bo.it.

Stefano Pongolini (S)

Risk Analysis and Genomic Epidemiology Unit, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, 43126, Italy. Electronic address: stefano.pongolini@izsler.it.

Laura Soliani (L)

Risk Analysis and Genomic Epidemiology Unit, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, 43126, Italy. Electronic address: laura.soliani@izsler.it.

Andreas Wille (A)

Institute for Hygiene and Environment, City of Hamburg, 20539 Hamburg, Germany. Electronic address: andreas.wille@hu.hamburg.de.

Sandra Rojak (S)

Department of Microbiology and Hospital Hygiene, Bundeswehr Central Hospital Koblenz, 56070 Koblenz, Germany. Electronic address: sandrarojak@bundeswehr.org.

Ralf Matthias Hagen (RM)

Department of Microbiology and Hospital Hygiene, Bundeswehr Central Hospital Koblenz, 56070 Koblenz, Germany. Electronic address: ralfmatthiashagen@bundeswehr.org.

Jürgen May (J)

Bernhard Nocht Institute for Tropical Medicine Hamburg, 20359 Hamburg, Germany; University Medical Center Hamburg-Eppendorf (UKE), Tropical Medicine II, Hamburg, Germany. Electronic address: may@bnitm.de.

A B Pranada (AB)

Department of Medical Microbiology, MVZ Dr. Eberhard & Partner Dortmund, Dortmund, Balkenstrasse 17-19, 44137 Dortmund, Germany. Electronic address: apranada@labmed.de.

Markus Kostrzewa (M)

Bruker Daltonics GmbH & Co. KG, 28359 Bremen, Germany. Electronic address: markus.kostrzewa@bruker.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH